Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Αρχειοθήκη ιστολογίου
-
▼
2023
(272)
-
▼
Φεβρουαρίου
(141)
-
▼
Φεβ 19
(16)
- An integrated strategy to identify COVID‐19 causal...
- Monitoring of SARS‐CoV‐2 concentration and circula...
- Pustular psoriasis in Malaysia: A review of the Ma...
- Nuclear membrane irregularity in high‐grade urothe...
- Primary tumor resection improves survival of gastr...
- Impact of Exercise and Detraining on Signs of Pube...
- LRRK2 Quantification in Cerebrospinal Fluid of Pat...
- LRRK2 Inhibition by BIIB122 in Healthy Participant...
- Spermidine reduced neuropathic pain in chronic con...
- Xenogeneic collagen matrix versus connective tissu...
- Tixagevimab/Cilgavimab Treatment and Cardiovascula...
- Recombinant measles virus encoding the spike prote...
- The Ixodes ricinus salivary gland proteome during ...
- Characterization of protein-based risk signature t...
- Diagnostic Confirmation of Choroidal Lymphoma by A...
- Acute Posterior Multifocal Placoid Pigment Epithel...
-
▼
Φεβ 19
(16)
- ► Ιανουαρίου (131)
-
▼
Φεβρουαρίου
(141)
-
►
2022
(2066)
- ► Δεκεμβρίου (80)
- ► Σεπτεμβρίου (170)
- ► Φεβρουαρίου (190)
- ► Ιανουαρίου (203)
-
►
2021
(7399)
- ► Δεκεμβρίου (186)
- ► Σεπτεμβρίου (472)
- ► Φεβρουαρίου (851)
-
►
2020
(2517)
- ► Δεκεμβρίου (792)
- ► Σεπτεμβρίου (21)
- ► Φεβρουαρίου (28)
-
►
2019
(12076)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (4765)
- ► Ιανουαρίου (5155)
-
►
2018
(3144)
- ► Δεκεμβρίου (3144)
Ετικέτες
Πληροφορίες
Τετάρτη 22 Νοεμβρίου 2017
Tooth and fail: Four-year wait for dental treatment
Waiting period for public dental treatment in the Northern Territory has blown out from 30.8 months to almost 45.7 months. TERRITORIANS with tooth trouble are waiting almost four years for dental treatment in the public health system, latest figures show.
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2hXmBQH
via IFTTT
Multiple overlapping systematic reviews facilitate the origin of disputes: the case of thrombolytic therapy for pulmonary embolism
Source:Journal of Clinical Epidemiology
Author(s): Nicoletta Riva, Livia Puljak, Lorenzo Moja, Walter Ageno, Holger Schünemann, Nicola Magrini, Alessandro Squizzato
ObjectiveTo explore disagreements in multiple systematic reviews (SRs) assessing the benefit-to-harm ratio of thrombolytic therapy in patients with intermediate-risk pulmonary embolism (PE).Study Design and SettingMEDLINE, EMBASE, CDSR and DARE were searched up to April 14, 2016. We included SRs and guidelines that evaluated thrombolytic therapy, compared to anticoagulation alone, in intermediate-risk PE. We calculated pooled risk ratio (RR) and absolute risk difference (RD), with interquartile range (IQR), for all-cause mortality, recurrent PE and major bleeding.ResultsWe marked PEITHO, the largest trial, as a research milestone. Since its release in 2014, twelve SRs (2-15 included trials) and two major guidelines were published. Studies were concordant in reporting that thrombolysis reduced all-cause mortality (median RD -1.55%, IQR -1.60 to -1.40%; median RR 0.55, IQR 0.48-0.61). Discordant results were found for major bleeding (median RD 4.70%, IQR 0.90-5.70%), with SRs reporting results in opposite directions. Relevant magnitude of effects and precision for benefits and harms were never pre-specified.ConclusionFourteen evidence syntheses were published within 25 months. Conclusions suggested mortality reduction associated with thrombolytics. Therapy harm was more dispersed and alternatively considered. Interpretation of the benefit-to-harm ratio was elusive, and modest incremental advantages might or not be important, facilitating the origin of disputes.
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2iGIpgU
via IFTTT
Response Regarding Surgical Techniques for Retrograde Parotidectomy
Source:American Journal of Otolaryngology
Author(s): Maxwell Kligerman, Uchechukwu Megwalu, Davud Sirjani
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2iJ0BpX
via IFTTT
Noise exposure while commuting in Toronto - a study of personal and public transportation in Toronto
Abstract
Background
With an increasing proportion of the population living in cities, mass transportation has been rapidly expanding to facilitate the demand, yet there is a concern that mass transit has the potential to result in excessive exposure to noise, and subsequently noise-induced hearing loss.
Methods
Noise dosimetry was used to measure time-integrated noise levels in a representative sample of the Toronto Mass Transit system (subway, streetcar, and buses) both aboard moving transit vehicles and on boarding platforms from April – August 2016. 210 measurements were conducted with multiple measurements approximating 2 min on platforms, 4 min within a vehicle in motion, and 10 min while in a car, on a bike or on foot. Descriptive statistics for each type of transportation, and measurement location (platform vs. vehicle) was computed, with measurement locations compared using 1-way analysis of variance.
Results
On average, there are 1.69 million riders per day, who are serviced by 69 subway stations, and 154 streetcar or subway routes. Average noise level was greater in the subway and bus than in the streetcar (79.8 +/− 4.0 dBA, 78.1 +/− 4.9 dBA, vs 71.5 +/−1.8 dBA, p < 0.0001). Furthermore, average noise measured on subway platforms were higher than within vehicles (80.9 +/− 3.9 dBA vs 76.8 +/− 2.6 dBA, p < 0.0001). Peak noise exposures on subway, bus and streetcar routes had an average of 109.8 +/− 4.9 dBA and range of 90.4–123.4 dBA, 112.3 +/− 6.0 dBA and 89.4–128.1 dBA, and 108.6 +/− 8.1 dBA and 103.5–125.2 dBA respectively. Peak noise exposures exceeded 115 dBA on 19.9%, 85.0%, and 20.0% of measurements in the subway, bus and streetcar respectively.
Conclusions
Although the mean average noise levels on the Toronto transit system are within the recommended level of safe noise exposure, cumulative intermittent bursts of impulse noise (peak noise exposures) particularly on bus routes have the potential to place individuals at risk for noise induced hearing loss.
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2zdA9v4
via IFTTT
Attempting to validate the overtriage/undertriage matrix at a Level I trauma center
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2z5yqrk
via IFTTT
Pre-diagnostic dynamic HPV16 IgG seropositivity and risk of oropharyngeal cancer: Methodological issues
We were interested to read the paper authored by Anderson and colleagues that was published in the journal of Oral Oncology in October 2017 [1]. The authors aimed to examine the association of HPV16 antibodies (Abs) and oropharyngeal cancer (OPC) risk in sera obtained prior to clinical diagnosis. They found that Abs to E2 were strongly associated with cases 0–2 years pre- diagnosis (odds ratio (OR): 150.1; 95% confidence interval (CI): 27.4–1040.0) and HPV status (OR: 35.6; 95% CI: 8.7–200.0). Although their study makes valuable contribution to the area, some methodological issues need to be taken into account.
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2mUOsTl
via IFTTT
Small-diameter compression screws completely embedded in bone for rigid internal fixation of the condylar head of the mandible
Complications after open reduction and internal fixation of the condylar head include irritation of the sensitive soft tissues surrounding the temporomandibular joint (TMJ) caused by permanent friction from the screw head,1 and resorption beneath the screw heads because of bony remodelling around the lateral pole.1,2 However, a second operation can risk damage to the facial nerve.
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2A3HM8o
via IFTTT
What to do with medialized tympanostomy tubes? A survey of pediatric otolaryngologists
Tympanostomy tube placement is the most common surgical procedure performed in children. Medial migration of a tympanostomy tube is a rare occurrence where the tube migrates into the middle ear cavity as opposed to its normal extrusion into the external auditory canal. Whether medialized tympanostomy tubes should be surgically removed in asymptomatic patients is controversial. The objective of this study was to determine experience and management approach of medialized tympanostomy tubes among pediatric otolaryngologists.
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2zg1E7e
via IFTTT
Demonstration of analgesic effect of intranasal ketamine and intranasal fentanyl for postoperative pain after pediatric tonsillectomy
Tonsillectomy is one of the oldest and most commonly performed surgical procedure in otolaryngology. Postoperative pain management is still an unsolved problem. In this study, our aim is to demonstrate the efficacy of intranasal ketamine and intranasal fentanyl for postoperative pain relief after tonsillectomy in children.
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2BhbzuC
via IFTTT
Childhood hearing loss is a key feature of CAPOS syndrome: A case report
CAPOS syndrome (cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss) is a rare neurological disorder, recently associated with the c.2452G > A hotspot mutation in the ATP1A3 gene, with sensorineural hearing loss as a prominent feature. We herein report on a girl who has experienced hearing loss for three years following an initial encephalitic episode when aged 15 months old. CAPOS was diagnosed only when she was six years old by targeted testing whilst she displayed optic atrophy, cerebellar signs and areflexia.
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2zdgGuu
via IFTTT
Identification of two novel pathogenic compound heterozygous MYO7A mutations in Usher syndrome by whole exome sequencing
The current study aims to identify the pathogenic sites in a core pedigree of Usher syndrome (USH). A core pedigree of USH was analyzed by whole exome sequencing (WES). Mutations were verified by polymerase chain reaction (PCR) amplification and Sanger sequencing. Two pathogenic variations (c.849+2T>C and c.5994G>A) in MYO7A were successfully identified and individually separated from parents. One variant (c.849+2T>C) was nonsense mutation, causing the protein terminated in advance, and the other one (c.5994G>A) located near the boundary of exon could cause aberrant splicing.
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2BflJMm
via IFTTT
Spontaneous retropharyngeal and mediastinal thoracic duct cyst in an infant with respiratory distress
Thoracic duct cysts (TDC) within the retropharyngeal space and mediastinum are exceeding rare lesions, with the majority related to trauma or neoplasm. We describe a case of an otherwise healthy 8-month-old boy who presented with severe respiratory distress, which was found to be caused by a large, spontaneous TDC occupying most the retropharyngeal and mediastinal space. To our knowledge, this is the youngest patient to date presenting with TDC. Ultimately, his TDC was completely resolved with sclerotherapy, however the patient's age and size presented unique challenges to his medical management, which we describe below.
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2zdKE1a
via IFTTT
Genetic analysis of CLDN14 in the Chinese population affected with non-syndromic hearing loss
The CLDN14 gene, encoding the tight junction protein Claudin-14, has been proposed as a candidate causative gene affecting autosomal recessive non-syndromic hearing loss (ARNSHL). Genetic analysis of nonsynonymous single-nucleotide variations (nsSNVs) in CLDN14 has been performed in different populations. The role of CLDN14 nsSNVs in contributing to hearing loss in Chinese populations would be investigated in this study.
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2BezCu5
via IFTTT
Risk factors for QTc interval prolongation
Abstract
Purpose
Prolongation of the QTc interval may result in Torsade de Pointes, a ventricular arrhythmia. Numerous risk factors for QTc interval prolongation have been described, including the use of certain drugs. In clinical practice, there is much debate about the management of the risks involved. In this study, we quantified the effect of these risk factors on the length of the QTc interval.
Methods
We analyzed all ECGs that were taken during routine practice between January 2013 and October 2016 in the Spaarne Gasthuis, a general teaching hospital in the Netherlands. We collected laboratory values in the week before the ECG recording and the drugs prescribed. For the identification of risk factors, we used multilevel linear regression analysis to correct for multiple ECG recordings per patient.
Results
We included 133,359 ECGs in our study, taken in 40,037 patients. Patients using one QT-prolonging drug had a 11.08 ms (95% CI 10.63–11.52; p < 0.001) longer QTc interval. Patients using two QT-prolonging drugs had a 3.04 ms (95% CI 2.06–4.02; p < 0.001) increase in the QTc interval compared to patients using one QT-prolonging drug. Women had a longer QTc interval compared to men (16.30 ms 95% CI 14.59–18.01; p < 0.001). The QTc interval increased with increasing age, but the difference between men and women diminished. Other independent risk factors that significantly prolonged the QTc interval with at least 10 ms were hypokalemia, hypocalcemia, and the use of loop diuretics.
Conclusion
We identified and quantified various risk factors for QTc interval prolongation.
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2zfUH63
via IFTTT
Αναζήτηση αυτού του ιστολογίου
! # Ola via Alexandros G.Sfakianakis on Inoreader
-
Summary Low-fidelity, simulation-based psychomotor skills training is a valuable first step in the educational approach to mastering com...
-
Abstract Purpose Clinicians must balance the risks from hypotension with the potential adverse effects of vasopressors. Experts have rec...
-
Does CBD Oil Lower Blood Pressure? This article was originally published at SundayScaries." Madeline Taylor POSTED ON January 13, 20...